"Feces" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
Descriptor ID |
D005243
|
MeSH Number(s) |
A12.459
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Feces".
Below are MeSH descriptors whose meaning is more specific than "Feces".
This graph shows the total number of publications written about "Feces" by people in this website by year, and whether "Feces" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 2 | 1 | 3 |
2012 | 1 | 2 | 3 |
2013 | 0 | 1 | 1 |
2014 | 7 | 3 | 10 |
2015 | 3 | 1 | 4 |
2016 | 4 | 4 | 8 |
2017 | 4 | 3 | 7 |
2018 | 0 | 2 | 2 |
2019 | 1 | 2 | 3 |
2020 | 3 | 1 | 4 |
2022 | 0 | 3 | 3 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Feces" by people in Profiles.
-
Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024 Jul 01; 7(7):e2423671.
-
Incidence, Etiology, and Healthcare Utilization for Acute Gastroenteritis in the Community, United States. Emerg Infect Dis. 2022 11; 28(11):2234-2242.
-
Reusing a prepaid health plan's fecal immunochemical tests for microbiome associations with colorectal adenoma. Sci Rep. 2022 08 31; 12(1):14801.
-
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022 06 10; 3(6):371-387.e9.
-
Challenges in Reaching Medicaid and Medicare Enrollees in a Mailed Fecal Immunochemical Test Program. J Community Health. 2020 10; 45(5):916-921.
-
Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program. Gastroenterology. 2020 11; 159(5):1695-1704.e1.
-
Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening. Sci Rep. 2020 02 12; 10(1):2441.
-
Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial. Trials. 2020 Jan 15; 21(1):91.
-
Reproducibility, stability, and accuracy of microbial profiles by fecal sample collection method in three distinct populations. PLoS One. 2019; 14(11):e0224757.
-
Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study. Cancer. 2020 02 01; 126(3):540-548.